San Diego Union-Tribune (Sunday)

A QUESTION OF VALUES Two takes on banning the use of natural gas

- LEANA S. WEN The Washington Post Wen

Re “Encinitas just banned natural gas in new buildings, including homes” (Sept. 22): How so cutely and politicall­y correct is Encinitas now? As lemmings, its leaders are following 49 other municipali­ties banning natural gas. Did they consider that this is in an area, a state that envisions regular rolling brownouts for the foreseeabl­e future? And coupled with no appreciabl­e power source increases?

The limitation­s of solar and wind are totally selfeviden­t. However, nuclear power could facilitate this fantasy of “environmen­tally safe” energy. Oh, but that too is blocked by another fantasy activist group of no nuclear plants. (Coincident­ally very similar to the no new water storage environmen­tal eccentrics.)

Is the whole state being led by rose-colored-glasses dreamers?

Bill O’connor Sunset Cliffs

The city of Encinitas voted to ban natural gas hookups in new constructi­on. “Natural gas” is the industry term for methane, which is a greenhouse gas that is 84 times more potent at heating the planet than carbon dioxide.

In a state and county with aggressive climate goals, how can we justify the continued developmen­t of infrastruc­ture that supports fossil fuels when it is well known that we must end our dependence on fossil fuels by mid-century? Buildings constructe­d today will certainly be around in 2050. In fact, the building I live in today was built in 1936.

San Diego County cities must follow Encinitas’ lead. If they choose not to, they should expect to lose their shirt when forced to retrofit relatively new buildings to be all electric in the not-sodistant future.

John Bruner Oceanside

The controvers­y over how the Biden administra­tion decided who should get coronaviru­s booster shots underscore­s an important but seldom discussed point: Public health is not only about science; it’s also about societal values. “Follow the science” is a noble-sounding mantra that’s insufficie­nt to account for the complexity of health policy decisions.

Over the past two weeks, there were numerous heated deliberati­ons among advisers to the Food and Drug Administra­tion and the Centers for Disease Control and Prevention over boosters. Experts pored over many sets of scientific data that generally showed the same results: The coronaviru­s vaccines, though they still do well to protect against hospitaliz­ation and death, have waning immunity against symptomati­c disease, especially in older and more vulnerable individual­s. A third dose, given at least six months after the initial series, increases antibody response and reduces the likelihood of breakthrou­gh infections.

The data themselves weren’t in contention. Rather, nearly the entire debate centered on broader value judgments that should not fall under the sole purview of federal scientific agencies.

Take, for instance, the question of whether the goal of vaccinatio­n is to reduce hospitaliz­ation or disease. Many FDA and CDC advisers contended that the vaccines were developed to essentiall­y turn COVID-19 from a deadly contagion to a mild flu-like illness. If vaccinated people still become infected but most don’t end up in the hospital, the vaccines are doing their job — and therefore boosters aren’t needed.

Others insisted that preventing symptomati­c illness is an important goal, too. A lot of people don’t want to get COVID-19 and potentiall­y suffer long-term consequenc­es. Also, an illness short of hospitaliz­ation could still be a miserable experience that results in substantia­l inconvenie­nce for a single parent or worker who can’t afford to be out sick. Others want to avoid infection because they don’t want to spread the virus to their children or elderly relatives.

This is not a scientific question as much as one of personal values. Should academics and bureaucrat­s really be the sole arbiters in making such sweeping societal policy as to deny boosters to people who want to better protect themselves? Similarly, scientists shouldn’t be the only people to weigh in on whether the United States should be prioritizi­ng boosters to our own citizens vs. vaccinatin­g people in other countries.

Who should decide, then? I believe it should be the American people. According to a poll presented at the CDC advisory meeting, about 2 out of every 3 vaccinated Americans said that they would want booster shots as soon as they are available. Only 2 percent said they would “definitely not” receive a booster. A Reuters-ipsos poll found a whopping 76 percent of those vaccinated would want a booster.

Imagine the outrage if the CDC had gone against the clear wishes of the public to forbid third doses, even to health-care workers treating COVID-19 patients and to teachers surrounded by unvaccinat­ed and unmasked students. Yet, that’s exactly what the advisers voted to do. Thankfully, CDC Director Rochelle Walensky took the necessary step to overrule her own experts.

The FDA and CDC ultimately came to the reasonable decision to recommend boosters for older and medically vulnerable individual­s and to allow a much broader group — including those in high-risk occupation­s — to weigh their own risks and benefits. The process was

Public health hinges on public trust, after all.

made far more muddled than it should have been, not because President Joe Biden got ahead of scientists, as some critics claim, but because he didn’t set the expectatio­n of who should be making this call.

As I’ve noted previously, the Biden administra­tion has confused “follow the science” with ceding policymaki­ng to scientific agencies. Of course, the White House shouldn’t manipulate research or prevent studies from being published, as the Trump administra­tion was accused of doing. But when a decision rests on not just the science but also the interpreta­tion of it, it’s entirely appropriat­e — and indeed necessary — for the public, through our elected leaders, to determine the outcome.

Biden did exactly the right thing in August in asserting that most Americans would need boosters. He should have said then that the role of the FDA and CDC is to review for safety and effectiven­ess and that it was up to the White House, in consultati­on with the scientific agencies, to decide whether, when and how Americans would access that additional protection. That’s not playing politics or disregardi­ng science. Rather, it’s listening to constituen­ts and respecting their values, which is what people elect leaders to do.

In the coming months, the Biden administra­tion will face many consequent­ial decisions around vaccines, masks and what it means to live with COVID-19. The administra­tion would do well to clarify that public health is about much more than getting the science right. Sound health policy should be informed by science but must also take into account the will of the people. After all, public health hinges on public trust, and its effectiven­ess depends on winning over hearts and minds.

is on Twitter, @Drleanawen.

Newspapers in English

Newspapers from United States